Literature DB >> 19350156

[Hepatitis B vaccine in patients with human immunodeficiency virus infection].

Carlos A Ramírez O1, Daniel G Fernández A, Sandra L Valderrama B, Carlos H Gómez Q, José R Támara R, Carlos A Alvarez M.   

Abstract

Hepatitis B is a public health problem in the entire world, mainly among HIV infected people in whom the coinfection change the course, natural history and morbi-mortality of the disease. Because of this, it is imperative to design strategies to prevent hepatitis B infection in HIV patients. Vaccination is the most important tool for prevention, although its efficacy varies according to immunologic and virologic status of the patient.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19350156     DOI: /S0716-10182009000100004

Source DB:  PubMed          Journal:  Rev Chilena Infectol        ISSN: 0716-1018            Impact factor:   0.520


  2 in total

1.  [Use of hepatitis B AS04C adjuvanted vaccine in HIV patients].

Authors:  M Fernández-Prada; O D Rodríguez-Fonseca; A M Brandy-García; P Alonso-Penanes; I Huerta-González; F Fernández-Noval
Journal:  Rev Esp Quimioter       Date:  2018-03-19       Impact factor: 1.553

2.  Hepatitis B and C virus infection among HIV patients within the public and private healthcare systems in Chile: A cross-sectional serosurvey.

Authors:  Thomas Weitzel; Fernanda Rodríguez; Luis Miguel Noriega; Alejandra Marcotti; Luisa Duran; Carla Palavecino; Lorena Porte; Ximena Aguilera; Marcelo Wolff; Claudia P Cortes
Journal:  PLoS One       Date:  2020-01-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.